Zynex, Inc.

NasdaqGS ZYXI

Zynex, Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 50.57

Zynex, Inc. Price to Earnings Ratio (P/E) is 50.57 on January 14, 2025, a 52.89% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Zynex, Inc. 52-week high Price to Earnings Ratio (P/E) is 61.39 on November 11, 2024, which is 21.41% above the current Price to Earnings Ratio (P/E).
  • Zynex, Inc. 52-week low Price to Earnings Ratio (P/E) is 32.84 on January 17, 2024, which is -35.05% below the current Price to Earnings Ratio (P/E).
  • Zynex, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 45.96.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NasdaqGS: ZYXI

Zynex, Inc.

CEO Mr. Thomas Sandgaard
IPO Date Feb. 25, 2004
Location United States
Headquarters 9655 Maroon Circle
Employees 1,100
Sector Health Care
Industries
Description

Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Similar companies

HSIC

Henry Schein, Inc.

USD 71.27

0.81%

MCK

McKesson Corporation

USD 593.73

1.48%

EDAP

EDAP TMS S.A.

USD 2.02

-2.42%

CAH

Cardinal Health, Inc.

USD 124.03

2.62%

PDCO

Patterson Companies, Inc.

USD 30.89

0.16%

OMI

Owens & Minor, Inc.

USD 14.74

1.17%

StockViz Staff

January 15, 2025

Any question? Send us an email